Ablynx Appoints CMO
This article was originally published in Scrip
Ablynx has appointed Robert K. Zeldin chief medical officer (CMO) – effective Dec. 1, 2015. Previously Zeldin held senior level clinical development positions at Merck & Co., Inc. and Novartis Pharmaceuticals Corp. Prior to his positions in the pharmaceutical industry, Zeldin spent several years in private practice and two years as medical officer at the FDA's centre for biologics evaluation and research.